期刊文献+

SD-OCT在新生血管性老年性黄斑变性随访中的作用 被引量:2

Role of spectral-domain optical coherence tomography in the follow-up of neovascular age-related macular degeneration
下载PDF
导出
摘要 谱域光学相干断层扫描技术(spectral-domain optical coherence tomography,SD-OCT)的革新可以协助我们更好地观察新生血管性老年性黄斑变性(neovascular agerelated macular degeneration,NVAMD)的病程进展,并且监测其治疗效果。抗血管内皮生长因子(anti-vascular endothelial growth factor,抗VEGF)药物治疗这种新型方法,已被证实可以有效治疗NVAMD,然而治疗后的长期随访和再治疗成为维持现有视力的关键问题。在抗VEGF治疗过程中,SD-OCT成像有助于早期识别脉络膜新生血管的复发。本文将进一步阐述在NVAMD患者接受玻璃体腔注射抗VEGF治疗后,SD-OCT在随访中的作用。 Advances in spectral - domain optical coherence tomography ( SD- OCT ) technology provide improved monitoring of progression and assistance in quantifying response to treatment modalities in neovascular age-related macular degeneration ( NVAMD ) . There is little doubt that anti-vascular endothelial growth factor ( anti-VEGF) drug therapy is becoming a new approach to the management of NVAMD, while long-term follow-up and necessary retreatments are the key issues to remain obtained visual acuity. SD-OCT imaging helps to identify early recurrence of choroidal neovascularization during treatment with anti-VEGF. This review discusses the present applications of the commercially available SD-OCT systems in the follow-up of after the injection of intravitreal anti-VEGF in NVAMD.
出处 《国际眼科杂志》 CAS 2014年第5期838-841,共4页 International Eye Science
关键词 老年性黄斑变性 脉络膜新生血管 血管内皮生长因子 光学相干断层扫描 age - related macular degeneration choroidal neovascularization vascular endothelial growth factor optical coherence tomography
  • 相关文献

参考文献6

二级参考文献94

  • 1吴秋菊,陈松.老年性黄斑变性的检查方法研究进展[J].中华眼底病杂志,2004,20(5):324-327. 被引量:1
  • 2中华医学会眼科学会眼底病学组.老年性黄斑变性临床诊断标准[J].眼底病,1987,3:3-3. 被引量:50
  • 3The CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related maeular degeneration, New Engl J Med, 2011, 364:1897 -1908. 被引量:1
  • 4Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration. New Engl J Med, 2004, 351 : 2805-2816. 被引量:1
  • 5Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. New Engl J Med, 2006, 355: 1419-1431. 被引量:1
  • 6Brown DM, Kaiser PK, Michels M, et al. Ranibizurnab versus verteporfin for neovascular age-related macular degeneration. New Engl J Med,2006, 355: 1432-1444. 被引量:1
  • 7Costa RA, Jorge R, Calucci I), et al. Intravitreal bevacizumab (or choroidal neovascularisation caused by age-related macular degeneration (IbeNA study) : results of a phase 1 escalation study. Invest Ophthalmol Vis Sei, 2006,47:4569-4578. 被引量:1
  • 8Lazic R, Gabric N. Intravitreally administered bevacizumab ( Avastin ) in minimally classic and occult choroidalneovascularization secondary to age-related macular degeneration. Graef Arch Clin Exp Ophthalmol, 2007, 245 : 68- 73. 被引量:1
  • 9Abraham ML, Cortes CF, Alvarez G, et al. lntravitreal bevacizumab therapy _for neovascular age related macular degeneration: a pilot study. Graef Arch Clin Exp Ophthalmol, 2007, 245:651-655. 被引量:1
  • 10Rich RM, Rosenfeld PJ, Puliafito CA, et al. Short-term safetyand efficacy of intravitreal bevaeizumab ( Avastin ) for neovascular age-related macular generation. Retina, 2006, 26: 495-511. 被引量:1

共引文献48

同被引文献37

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部